Monguillon V, Marston NA, Bohula EA, Park JG, et al. Lipoprotein(a) Levels, Risk of Cardiovascular Events and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial. Circulation 2026 May 25. doi: 10.1161/CIRCULATIONAHA.126.080999.
PMID: 42183757